Patent details
EP1368038
Title:
MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS
Basic Information
- Publication number:
- EP1368038
- PCT Application Number:
- PCT/US/2002/002256
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027134733
- PCT Publication Number:
- WO/2002/062350
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS
- French Title of Invention:
- MEDICAMENT POUR L'ADMINISTRATION D'AMIFOSTINE ET COMPOSES ASSOCIES
- German Title of Invention:
- MEDIKAMENT ZUR VERABREICHUNG VON AMIFOSTIN UND VERWANDTEN WIRKSTOFFEN
- SPC Number:
-
Dates
- Filing date:
- 04/02/2002
- Grant date:
- 12/09/2007
- EP Publication Date:
- 12/09/2007
- PCT Publication Date:
- 15/08/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/12/2003
- EP B1 Publication Date:
- 12/09/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/02/2008
- Expiration date:
- 04/02/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/02/2002
-
-
- Name:
- Medimmune Oncology Inc.
- Address:
- One Tower Bridge, 100 Front Street, West Conshohocken, PA 19428, United States (US)
Inventor
- Name:
- STOGNIEW Martin
- Address:
- United States (US)
Priority
- Priority Number:
- 775540
- Priority Date:
- 05/02/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/66;
Filing date |
Document type |
Number of pages |